As a recognized leader in the specialty pharmacy (SRx) marketplace, Bill has provided practical solutions for controlling high-cost injectables, infusables and emerging biotech products. In 2002 Bill founded Specialty Pharmacy Solutions to provide expert consultative services to clients in the specialty pharmacy niche. Examples of major engagements include the development of multiple therapy-specific treatment management programs, the creation of sales, contracting, and clinical delivery programs for more than thirty specialty pharmacies including the largest joint venture between a national PBM and a publicly traded specialty pharmacy, RFP development / SRx Vendor selection / Contracting / Program Implementation for major health plans, long-term strategic planning to build pharmacy valuation, due diligence on specialty pharmacy acquisitions , competitive intelligence and managed care strategies for Pharma, etc. Bill can be contacted at bsullivan0011@gmail.com or 407-792-2268

While maintaining a full consulting schedule, I was honored to be asked to serve as the interim Executive Director of The Specialty Pharmacy Association of America, a newly formed association representing the broad interests of the specialty pharmacy industry. SPAARx was created in response to a clear call from specialty pharmacies, specialty pharmaceutical manufacturers, payers and other organizations to form a self-governing, national association that broadly represents the professional and personal interests of all specialty pharmacy industry stakeholders. Membership grew from zero to more than 4,000 members nationally during my tenure. Advocacy efforts during that period tackled complex industry challenges including Federal Compounding regulations and Hi-Tech Act regulations.

Led national contracting team that closed more than 300 payer contracts. Pharma business development / fee-for-service programs for specialty pharmacy. Clinical program development.

Led easatern regional sales for innovative, capitated specialty management program.

Responsible for P&L for more than $1 billion in premium and ASO revenue across managed, PPO and Indemnity product lines.

Pilgrim Health Care was acquired by Harvard Community Health Plan.